Clinical Trials on Ranibizumab

Total 7 results

LEANDRO CABRAL ZACHARIAS
Novartis

Unknown

Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study

Glaucoma, Neovascular | Ranibizumab
Beijing Hospital

Completed

Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRVO

Branch Retinal Vein Occlusion | Ranibizumab | Laser Photocoagulation

China
Shanghai General Hospital, Shanghai Jiao Tong University...
RenJi Hospital; Shanghai 10th People's Hospital; Eye & ENT Hospital of Fudan... and other collaborators

Unknown

Multicenter Clinical Study of Anti-VEGF Treatment on High Risk Diabetic Retinopathy (DR)

Diabetic Retinopathy | Ranibizumab

China
Egyptian Biomedical Research Network

Completed

Subfoveal Choroidal Thickness and Visual Acuity After Intravitreal Injection of Ranibizumab in Diabetic Retinopathy

Diabetic Retinopathy | Visual Acuity | Ranibizumab | Subfoveal Choroidal Thickness | Intravitreal

Egypt
Sun Yat-sen University

Unknown

Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion

Retinal Vein Occlusion | Treatment | Ranibizumab | Photocoagulation Burn to Retina

China
Zagazig University
Cairo University

Completed

Intravitreal Ranibizumab Injection for Aggressive Versus Type 1 Prethreshold Retinopathy of Prematurity

Retinopathy of Prematurity | Ranibizumab | Retina Disease

Egypt
Tianjin Medical University Eye Hospital
Hebei Provincial Eye Hospital; Cangzhou Eye Hospital

Recruiting

A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy

Diabetic Retinopathy | Pars Plana Vitrectomy | Ranibizumab | Postoperative Recurrent Vitreous Hemorrhage

China

Clinical Trials on Ranibizumab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations